Logo image of EPO-H.CA

ENCANTO POTASH CORP (EPO-H.CA) Stock Fundamental Analysis

Canada - TSX-V:EPO-H - CA29251N4012 - Common Stock

0.06 CAD
-0.01 (-7.69%)
Last: 10/23/2025, 7:00:00 PM
Fundamental Rating

1

EPO-H gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 29 industry peers in the Chemicals industry. EPO-H has a bad profitability rating. Also its financial health evaluation is rather negative. EPO-H has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EPO-H has reported negative net income.
In the past year EPO-H had a positive cash flow from operations.
EPO-H had negative earnings in each of the past 5 years.
EPO-H had a negative operating cash flow in each of the past 5 years.
EPO-H.CA Yearly Net Income VS EBIT VS OCF VS FCFEPO-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of EPO-H (-1780.44%) is worse than 89.29% of its industry peers.
Industry RankSector Rank
ROA -1780.44%
ROE N/A
ROIC N/A
ROA(3y)-1495.39%
ROA(5y)-1216.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EPO-H.CA Yearly ROA, ROE, ROICEPO-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

EPO-H does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EPO-H.CA Yearly Profit, Operating, Gross MarginsEPO-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

EPO-H has about the same amout of shares outstanding than it did 1 year ago.
EPO-H has less shares outstanding than it did 5 years ago.
EPO-H has a worse debt/assets ratio than last year.
EPO-H.CA Yearly Shares OutstandingEPO-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EPO-H.CA Yearly Total Debt VS Total AssetsEPO-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

EPO-H has an Altman-Z score of -1893.40. This is a bad value and indicates that EPO-H is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EPO-H (-1893.40) is worse than 85.71% of its industry peers.
EPO-H has a debt to FCF ratio of 4551.75. This is a negative value and a sign of low solvency as EPO-H would need 4551.75 years to pay back of all of its debts.
EPO-H has a better Debt to FCF ratio (4551.75) than 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4551.75
Altman-Z -1893.4
ROIC/WACCN/A
WACCN/A
EPO-H.CA Yearly LT Debt VS Equity VS FCFEPO-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

2.3 Liquidity

EPO-H has a Current Ratio of 0.00. This is a bad value and indicates that EPO-H is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.00, EPO-H is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
EPO-H has a Quick Ratio of 0.00. This is a bad value and indicates that EPO-H is not financially healthy enough and could expect problems in meeting its short term obligations.
EPO-H has a worse Quick ratio (0.00) than 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
EPO-H.CA Yearly Current Assets VS Current LiabilitesEPO-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

EPO-H shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.34%.
EPS 1Y (TTM)-4.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.73%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EPO-H. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EPO-H.CA Price Earnings VS Forward Price EarningsEPO-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

EPO-H's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EPO-H is cheaper than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 245.73
EV/EBITDA N/A
EPO-H.CA Per share dataEPO-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EPO-H does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENCANTO POTASH CORP

TSX-V:EPO-H (10/23/2025, 7:00:00 PM)

0.06

-0.01 (-7.69%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners19.14%
Ins Owner ChangeN/A
Market Cap1.08M
Revenue(TTM)N/A
Net Income(TTM)-1775100
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 245.73
P/OCF 245.73
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.41%
OCF(TTM)0
OCFY0.41%
SpS0
BVpS-1.77
TBVpS-1.77
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1780.44%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1495.39%
ROA(5y)-1216.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4551.75
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z -1893.4
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100.85%
OCF growth 3YN/A
OCF growth 5YN/A

ENCANTO POTASH CORP / EPO-H.CA FAQ

Can you provide the ChartMill fundamental rating for ENCANTO POTASH CORP?

ChartMill assigns a fundamental rating of 1 / 10 to EPO-H.CA.


Can you provide the valuation status for ENCANTO POTASH CORP?

ChartMill assigns a valuation rating of 1 / 10 to ENCANTO POTASH CORP (EPO-H.CA). This can be considered as Overvalued.


Can you provide the profitability details for ENCANTO POTASH CORP?

ENCANTO POTASH CORP (EPO-H.CA) has a profitability rating of 0 / 10.